Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.77
-1.06-5.35%
At close: -
$18.37
-0.40-2.12%
After Hours: 6:59 PM EDT
Comments
Loading...
Cellebrite DI Analyst Ratings and Price Targets | NASDAQ:CLBT | Benzinga
Cellebrite DI Ltd has a consensus price target of $19.6 based on the ratings of 11 analysts. The high is $28 issued by Needham on April 2, 2025. The low is $10 issued by JP Morgan on August 9, 2023. The 3 most-recent analyst ratings were released by Needham on April 2, 2025, March 27, 2025, and March 10, 2025, respectively. With an average price target of $28 between Needham, there's an implied 52.41% upside for Cellebrite DI Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
Lake Street
JP Morgan
Craig-Hallum
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Cellebrite DI
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/02/2025 | Buy Now | 52.41% | Needham | Mike Cikos63% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2025 | Buy Now | 52.41% | Needham | Mike Cikos63% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 03/10/2025 | Buy Now | 52.41% | Needham | Mike Cikos63% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 02/14/2025 | Buy Now | 41.52% | Lake Street | Frank Takkinen40% | $17 → $26 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 52.41% | Needham | Mike Cikos63% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
| 02/11/2025 | Buy Now | 52.41% | JP Morgan | Brian Essex66% | $24 → $28 | Maintains | Overweight | Get Alert |
| 01/22/2025 | Buy Now | 52.41% | Needham | Mike Cikos63% | $21 → $28 | Maintains | Buy | Get Alert |
| 12/16/2024 | Buy Now | 30.64% | JP Morgan | Brian Essex66% | $22 → $24 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | 30.64% | Craig-Hallum | Jeff Van Rhee65% | $23 → $24 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 19.75% | JP Morgan | Brian Essex66% | $21 → $22 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | 14.31% | Needham | Mike Cikos63% | $17 → $21 | Maintains | Buy | Get Alert |
| 09/25/2024 | Buy Now | 25.19% | Craig-Hallum | Jeff Van Rhee65% | $20 → $23 | Maintains | Buy | Get Alert |
| 09/23/2024 | Buy Now | 25.19% | TD Cowen | Shaul Eyal78% | $20 → $23 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | -2.02% | Deutsche Bank | Jamie Shelton47% | $15 → $18 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | -7.46% | B of A Securities | Tal Liani75% | $13 → $17 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | -7.46% | JP Morgan | Brian Essex66% | $15 → $17 | Maintains | Overweight | Get Alert |
| 08/16/2024 | Buy Now | -7.46% | Lake Street | Frank Takkinen40% | $13.5 → $17 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | 8.86% | Craig-Hallum | Jeff Van Rhee65% | $16 → $20 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | -7.46% | Needham | Mike Cikos63% | $14 → $17 | Maintains | Buy | Get Alert |
| 08/14/2024 | Buy Now | -18.35% | JP Morgan | Brian Essex66% | $14 → $15 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | -23.79% | JP Morgan | Brian Essex66% | $12 → $14 | Maintains | Overweight | Get Alert |
| 05/24/2024 | Buy Now | -23.79% | Needham | Mike Cikos63% | $13.5 → $14 | Maintains | Buy | Get Alert |
| 04/19/2024 | Buy Now | -29.24% | Lake Street | Frank Takkinen40% | → $13 | Initiates | → Buy | Get Alert |
| 04/01/2024 | Buy Now | -12.91% | Craig-Hallum | Jeff Van Rhee65% | $14 → $16 | Maintains | Buy | Get Alert |
| 04/01/2024 | Buy Now | -29.24% | B of A Securities | Tal Liani75% | $12 → $13 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | -26.52% | Needham | Mike Cikos63% | $13 → $13.5 | Maintains | Buy | Get Alert |
| 03/13/2024 | Buy Now | — | William Blair | Jonathan Ho71% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 02/16/2024 | Buy Now | -34.68% | B of A Securities | Tomer Zilberman70% | → $12 | Upgrade | Neutral → Buy | Get Alert |
| 02/15/2024 | Buy Now | -29.24% | Needham | Mike Cikos63% | $10 → $13 | Maintains | Buy | Get Alert |
| 08/30/2023 | Buy Now | -45.57% | Needham | Mike Cikos63% | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/09/2023 | Buy Now | -45.57% | JP Morgan | Sterling Auty67% | $8 → $10 | Maintains | Overweight | Get Alert |
| 08/09/2023 | Buy Now | -45.57% | Needham | Mike Cikos63% | $7 → $10 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | -40.12% | Craig-Hallum | Jeff Van Rhee65% | → $11 | Initiates | → Buy | Get Alert |
| 05/17/2023 | Buy Now | -61.9% | Needham | Mike Cikos63% | → $7 | Reiterates | Buy → Buy | Get Alert |
| 05/11/2023 | Buy Now | -61.9% | Needham | Mike Cikos63% | → $7 | Reiterates | → Buy | Get Alert |
| 03/14/2023 | Buy Now | -61.9% | Needham | Mike Cikos63% | $6.5 → $7 | Maintains | Buy | Get Alert |
| 02/16/2023 | Buy Now | -64.62% | Needham | Mike Cikos63% | → $6.5 | Reiterates | → Buy | Get Alert |
| 08/12/2022 | Buy Now | -67.34% | B of A Securities | Tal Liani75% | $6.5 → $6 | Downgrade | Buy → Neutral | Get Alert |
| 08/12/2022 | Buy Now | -45.57% | Cowen & Co. | Shaul Eyal78% | $13 → $10 | Maintains | Outperform | Get Alert |
| 08/12/2022 | Buy Now | — | William Blair | Jonathan Ho71% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/11/2022 | Buy Now | -64.62% | Needham | Mike Cikos63% | $6 → $6.5 | Maintains | Buy | Get Alert |
| 05/13/2022 | Buy Now | -45.57% | Deutsche Bank | Jamie Shelton47% | $11 → $10 | Maintains | Buy | Get Alert |
| 05/13/2022 | Buy Now | -67.34% | Needham | Mike Cikos63% | $9.5 → $6 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cellebrite DI (CLBT) stock?
The latest price target for Cellebrite DI (NASDAQ:CLBT) was reported by Needham on April 2, 2025. The analyst firm set a price target for $28.00 expecting CLBT to rise to within 12 months (a possible 52.41% upside). 23 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cellebrite DI (CLBT)?
The latest analyst rating for Cellebrite DI (NASDAQ:CLBT) was provided by Needham, and Cellebrite DI reiterated their buy rating.
When was the last upgrade for Cellebrite DI (CLBT)?
The last upgrade for Cellebrite DI Ltd happened on March 13, 2024 when William Blair raised their price target to N/A. William Blair previously had a market perform for Cellebrite DI Ltd.
When was the last downgrade for Cellebrite DI (CLBT)?
The last downgrade for Cellebrite DI Ltd happened on August 12, 2022 when B of A Securities changed their price target from $6.5 to $6 for Cellebrite DI Ltd.
When is the next analyst rating going to be posted or updated for Cellebrite DI (CLBT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cellebrite DI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cellebrite DI was filed on April 2, 2025 so you should expect the next rating to be made available sometime around April 2, 2026.
Is the Analyst Rating Cellebrite DI (CLBT) correct?
While ratings are subjective and will change, the latest Cellebrite DI (CLBT) rating was a reiterated with a price target of $28.00 to $28.00. The current price Cellebrite DI (CLBT) is trading at is $18.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.